SCHEMBL867201

SCHEMBL867201

CN(C)c1ccccc1N=C=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.52
▸ TRPA1 O75762 1/20 0.41
▸ ALDH1A1 P00352 5/20 0.41
▸ MAPT P10636 4/20 0.41
▸ GAA P10253 3/20 0.41
▸ TP53 P04637 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.40
▸ TDP1 Q9NUW8 3/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ HTR6 P50406 1/20 0.36
▸ NSD2 O96028 1/20 0.36
▸ EGFR P00533 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ GABRA1 P14867 1/20 0.35
▸ GABRB2 P47870 1/20 0.35
▸ CHEK1 O14757 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30536712 1.00 CYP3A4 (0.52) CYP3A4TRPA1ALDH1A1MAPTGAA
SCHEMBL7787561 0.81 KMT2A (0.44) CYP3A4TRPA1ALDH1A1MAPTGAA
SCHEMBL7787560 0.81 KMT2A (0.44) CYP3A4TRPA1ALDH1A1MAPTGAA
SCHEMBL10514797 0.79 MAPT (0.40) ALDH1A1MAPTGAATP53TSHR
SCHEMBL5725150 0.79 ALDH1A1 (0.51) CYP3A4ALDH1A1MAPTGAATP53
SCHEMBL14180515 0.77 TDP1 (0.48) CYP3A4ALDH1A1MAPTGAASMN1; SMN2
SCHEMBL29395383 0.77 CYP3A4 (0.64) CYP3A4TRPA1ALDH1A1MAPTGAA
SCHEMBL15431 0.77 CYP3A4 (0.64) CYP3A4TRPA1ALDH1A1MAPTGAA
SCHEMBL27558099 0.76 CYP3A4 (0.44) CYP3A4TRPA1ALDH1A1MAPTKDM4E
SCHEMBL30882155 0.76 MAPT (0.45) ALDH1A1MAPTGAATP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107176925-A A kind of synthetic method of the cyclohexadione compounds of polysubstituted imidazoline 2,4 湖北科技学院 2017-09-19 — — CN claimed
EP-3298194-A2 METHODS FOR TREATING PAPERBOARDS AND PAPER MEDIA, AND ASSOCIATED PAPERBOARDS AND PAPER MEDIA BASF SE (DE) 2018-03-28 — — EP disclosed
CN-107176925-A A kind of synthetic method of the cyclohexadione compounds of polysubstituted imidazoline 2,4 湖北科技学院 2017-09-19 — — CN disclosed
CN-102917883-B Method for manufacturing Heat-sensitive recording material MITSUBISHI PAPER MILLS LTD 2015-01-14 — — CN disclosed
US-8785424-B2 ngCycloartanone derivatives with anticancer activity PIERRE FABRE MEDICAMENT (FR) 2014-07-22 — — US disclosed
CN-102917883-A Heat-sensitive recording material and method for manufacturing the same MITSUBISHI PAPER MILLS LTD 2013-02-06 — — CN disclosed
US-20120077777-A1 NGCYCLOARTANONE DERIVATIVES WITH ANTICANCER ACTIVITY CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2012-03-29 — — US disclosed
WO-2011019612-A1 BORON-CONTAINING SMALL MOLECULES AS ANTIPROTOZOAL AGENTS ANACOR PHARMACEUTICALS, INC. (US) 2011-02-17 — — WO disclosed
EP-1901745-A2 SYNERGISTIC MODULATION OF FLT3 KINASE USING AMINOPYRIMIDINES KINASE MODULATORS AND A FARNESYL TRANSFERASE INHIBITOR JANSSEN PHARMACEUTICA N.V. (BE) 2008-03-26 — — EP disclosed
EP-1898917-A1 AMINOPYRIMIDINES AS KINASE MODULATORS Janssen Pharmaceutica, N.V. (BE) 2008-03-19 — — EP disclosed
EP-0297996-A2 Lubricating oil compositions and fuel compositions containing substantially straight chain alkylphenyl poly(oxypropylene) aminocarbamates CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) 1989-01-04 — — EP disclosed
US-4329240-A POLYOXYALKYLENE AMINOCARBAMATES CHEVRON RESEARCH COMPANY (US) 1982-05-11 — — US disclosed
US-4294714-A Carboxylic acid salt containing deposit control additives and fuel and lube oil compositions containing them CHEVRON RESEARCH COMPANY (US) 1981-10-13 — — US disclosed
US-4289634-A SALT OF OXYACID ESTER OF PHOSPHORUS AND A HYDROCARBYL POLYOXYALKYLENE AMINOALKYL CARBAMATE CHEVRON RESEARCH COMPANY (US) 1981-09-15 — — US disclosed
US-4288612-A HYDROCARBYL-POLY(OXYALKYLENE) AMINOCARBAMATE FUEL ADDITIVES CHEVRON RESEARCH COMPANY (US) 1981-09-08 — — US disclosed
US-4274837-A HYDROCARBLY-POLYOXYALKYLENE-AMINOCARBAMATES CHEVRON RESEARCH COMPANY (US) 1981-06-23 — — US disclosed
US-4233168-A POLYOXYALKYLENE AMINOCARBAMATES CHEVRON RESEARCH COMPANY (US) 1980-11-11 — — US disclosed
US-4197409-A ANTIDEPOSITE FUEL ADDITIVES OR OIL ADDITIVES CHEVRON RESEARCH COMPANY (US) 1980-04-08 — — US disclosed
US-4191537-A ANTIDEPOSIT AGENTS CHEVRON RESEARCH COMPANY (US) 1980-03-04 — — US disclosed
US-3937824-A COMPOSITIONS AND METHODS OF KILLING INSECTS AND ACARIDS USING ALKOXYIMINO CARBAMOYLOXY PHOSPHORUS COMPOUNDS VELSICOL CHEMICAL CORPORATION (US) 1976-02-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120077777-A1 NGCYCLOARTANONE DERIVATIVES WITH ANTICANCER ACTIVITY PKD1, NME1, NGLY1 CYP3A4 1876/4885TRPA1 4002/4885ALDH1A1 787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback